453 related articles for article (PubMed ID: 16552773)
1. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
2. A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8.
Seitz S; Frege R; Jacobsen A; Weimer J; Arnold W; von Haefen C; Niederacher D; Schmutzler R; Arnold N; Scherneck S
Oncogene; 2005 Jan; 24(5):869-79. PubMed ID: 15580292
[TBL] [Abstract][Full Text] [Related]
3. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
[TBL] [Abstract][Full Text] [Related]
4. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.
Phillips KK; Welch DR; Miele ME; Lee JH; Wei LL; Weissman BE
Cancer Res; 1996 Mar; 56(6):1222-7. PubMed ID: 8640802
[TBL] [Abstract][Full Text] [Related]
5. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
6. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
7. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
9. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
10. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
[TBL] [Abstract][Full Text] [Related]
11. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
[TBL] [Abstract][Full Text] [Related]
12. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
14. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
15. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein.
Phillips KK; White AE; Hicks DJ; Welch DR; Barrett JC; Wei LL; Weissman BE
Mol Carcinog; 1998 Feb; 21(2):111-20. PubMed ID: 9496911
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2.
Gruber AD; Pauli BU
Cancer Res; 1999 Nov; 59(21):5488-91. PubMed ID: 10554024
[TBL] [Abstract][Full Text] [Related]
18. Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
Klebig C; Seitz S; Arnold W; Deutschmann N; Pacyna-Gengelbach M; Scherneck S; Petersen I
Cancer Res; 2005 Jan; 65(2):394-400. PubMed ID: 15695379
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.
Negrini M; Sabbioni S; Possati L; Rattan S; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Mar; 54(5):1331-6. PubMed ID: 8118824
[TBL] [Abstract][Full Text] [Related]
20. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
